Fortress Biotech resumed with a Buy at Roth MKM
In: The Fly, 2024-03-15
serialPeriodical
Zugriff:
Roth MKM resumed coverage of Fortress Biotech with a Buy rating and $10 price target. The company continues to build out a diverse pipeline of 'high potential' clinical stage assets, [...]
Titel: |
Fortress Biotech resumed with a Buy at Roth MKM
|
---|---|
Zeitschrift: | The Fly, 2024-03-15 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|